The recently published executive summary from ASTRO/ASCO/AUA hypofractionated radiation therapy for localized prostate cancer states "Five-fraction prostate ultrahypofractionation at doses above 3625 cGy to the planning target volume is not suggested outside the setting of a clinical trial or multi-institutional registry due to risk of late toxicity. Strength of recommendation: Conditional; Quality of evidence: Moderate; Consensus: 100%." If your current practice is 4000 cGy in 5 fractions, for example, do you plan to change your regimen based on this publication?
Very valid points. Everyone should remember that t...
Off of the above mentioned protocol, I have common...
It should be noted that note all SBRT is created e...
I have personally used the fractionation schemes o...
Thank you! Very practical and helpful comments @Da...